Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Thiopurines in inflammatory bowel disease: new strategies for optimization of pharmacotherapy?

× No keyword cloud information.

45 in total

1. ITPA genotyping test does not improve detection of Crohn's disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression.

Authors: D Allorge; R Hamdan; F Broly; C Libersa; J-F Colombel
Journal: Gut Date: 2005-04 Impact factor: 23.059

2. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease.

Authors: C Cuffari; S Hunt; T Bayless
Journal: Gut Date: 2001-05 Impact factor: 23.059

3. Therapeutic drug monitoring of azathioprine and 6-mercaptopurine metabolites in Crohn disease.

Authors: J Belaiche; J P Desager; Y Horsmans; E Louis
Journal: Scand J Gastroenterol Date: 2001-01 Impact factor: 2.423

4. Simultaneous determination of 6-thioguanine and methyl 6-mercaptopurine nucleotides of azathioprine in red blood cells by HPLC.

Authors: T Dervieux; R Boulieu
Journal: Clin Chem Date: 1998-03 Impact factor: 8.327

5. 6-Mercaptopurine in the management of inflammatory bowel disease: short- and long-term toxicity.

Authors: D H Present; S J Meltzer; M P Krumholz; A Wolke; B I Korelitz
Journal: Ann Intern Med Date: 1989-10-15 Impact factor: 25.391

6. The utility of 6-thioguanine metabolite levels in managing patients with inflammatory bowel disease.

Authors: Benjamin A Goldenberg; Patricia Rawsthorne; Charles N Bernstein
Journal: Am J Gastroenterol Date: 2004-09 Impact factor: 10.864

7. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience.

Authors: W R Connell; M A Kamm; J K Ritchie; J E Lennard-Jones
Journal: Gut Date: 1993-08 Impact factor: 23.059

8. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment.

Authors: Luc J J Derijks; Dirk J de Jong; Lennard P L Gilissen; Leopold G J B Engels; Piet M Hooymans; Jan B M J Jansen; Chris J J Mulder
Journal: Eur J Gastroenterol Hepatol Date: 2003-01 Impact factor: 2.566

9. Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine.

Authors: Marla C Dubinsky; Edward J Feldman; Maria T Abreu; Stephan R Targan; Eric A Vasiliauskas
Journal: Am J Gastroenterol Date: 2003-05 Impact factor: 10.864

10. Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.

Authors: U Hindorf; E Lyrenäs; A Nilsson; K Schmiegelow
Journal: Scand J Gastroenterol Date: 2004-11 Impact factor: 2.423

3 in total

Review 1. Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.

Authors: Teun van Gelder; Ron H van Schaik; Dennis A Hesselink
Journal: Nat Rev Nephrol Date: 2014-09-23 Impact factor: 28.314

Review 2. Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors: Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal: Clin Pharmacokinet Date: 2018-09 Impact factor: 6.447

3. Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore.

Authors: Jia Qi Yeo; Hua Heng McVin Cheen; Amanda Wong; Teong Guan Lim; Balram Chowbay; Wai Fook Leong; Chunyan Wang; Ennaliza Salazar; Webber Pak Wo Chan; San Choon Kong; Wan Chee Ong
Journal: JGH Open Date: 2022-08-01

3 in total